Filing Details
- Accession Number:
- 0001144204-14-022268
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-11 21:02:52
- Reporting Period:
- 2014-04-09
- Filing Date:
- 2014-04-11
- Accepted Time:
- 2014-04-11 21:02:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559515 | S.p.a. Genextra | Via G. De Grassi, 11 Milan L6 20123 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-04-09 | 318,695 | $320.00 | 5,620,195 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-04-10 | 865,381 | $10.40 | 6,485,576 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2014-04-10 | 30,623 | $293.91 | 6,454,953 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant to Purchase Common Stock | Disposition | 2014-04-10 | 865,381 | $0.00 | 865,381 | $10.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-20 | No | 4 | X | Direct |
Footnotes
- Represents shares of common stock sold by Genextra S.p.A. in a secondary offering pursuant to a registration statement on Form S-3 (File No. 333-194974) that was completed on April 9, 2014.
- Warrant to purchase an aggregate of 865,381 shares of common stock was exercised on a cashless basis by Genextra S.p.A. on April 10, 2014, resulting in the issuance by the Issuer of an aggregate of 834,758 shares of common stock based on a fair market value of $293.91 per share, as determined by the average of the high ($301.80) and low ($286.01) trading price on April 9, 2014, the trading day immediately preceding the date of exercise.
- This warrant is immediately exercisable.
Billionaire Hedge Funds
